Camurus AB (CAMX) NPV

Sell:687.00 SEKBuy:688.00 SEKPrice decreased1.00 SEK (0.15%)

Prices delayed by at least 15 minutes
Sell:687.00 SEK
Buy:688.00 SEK
Change:Price decreased1.00 SEK (0.15%)
Deal now
Prices delayed by at least 15 minutes
Sell:687.00 SEK
Buy:688.00 SEK
Change:Price decreased1.00 SEK (0.15%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.

Key people

Behshad Sheldon
President
Fredrik Tiberg
Chief Executive Officer, Chief Scientific Officer, Director
Anders Vadsholt
Chief Financial Officer
Markus Johnsson
Senior Vice President R and D
Torsten Malmstroem
Chief Technical Officer
Bo Anders Caspersson Tarras-Wahlberg
Vice President, General Counsel
Annette Mattsson
Vice President - Regulatory Affairs
Agneta Svedberg
Vice President - Clinical Development
Fredrik Joabsson
Chief Business Development Officer
Richard Jameson
Chief Commercial Officer
Per Olof Wallstroem
Independent Chairman of the Board
Stefan Kenth Persson
Director
Elisabeth Bjork
Independent Director
Hege Hellstroem
Independent Director
Erika Sderberg Johnsson
Independent Director
Click to see more

Key facts

  • Shares in issue
    59.85m
  • EPIC
    CAMX
  • ISIN
    SE0007692850
  • Location
    Sweden
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    SEK 41.29bn
  • Employees
    280
  • Exchange
    Stockholm Stock Exchange
  • Index
    SX All Share PI Market Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.